|
| | Publication Year | Title | Author(s) |
| 41 | Dec-2020 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Chia, Puey Ling ; Russell, Prudence; Asadi, Khashi; Thapa, Bibhusal ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Eriksson, Ulf; Scott, Andrew M ; John, Thomas |
| 42 | 8-Oct-2018 | Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry Victoria. | Ong, Wee Loon ; Foroudi, Farshad ; Evans, Sue; Millar, Jeremy |
| 43 | 5-Apr-2011 | Antibodies in oncology. | Pillay, Vinochani; Gan, Hui K ; Scott, Andrew M |
| 44 | 23-Nov-2023 | Antibody and immunotherapy in diffuse large B-cell lymphoma. | Barraclough, Allison ; Hawkes, Eliza A |
| 45 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
| 46 | 3-Dec-2021 | Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them? | Parakh, Sagun ; Nicolazzo, Joseph; Scott, Andrew M ; Gan, Hui K |
| 47 | 8-May-2020 | Antibody Targeting of Eph Receptors in Cancer. | Janes, Peter W ; Vail, Mary E; Gan, Hui K ; Scott, Andrew M |
| 48 | 16-Oct-2020 | Antibody-Drug Conjugates for Cancer Therapy. | Hafeez, Umbreen ; Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M |
| 49 | 11-Jul-2016 | Antibody-Drug Conjugates for Cancer Therapy. | Parslow, Adam C; Parakh, Sagun ; Lee, Fook-Thean; Gan, Hui K ; Scott, Andrew M |
| 50 | Nov-2017 | Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells. | Gan, Hui K ; van den Bent, Martin; Lassman, Andrew B; Reardon, David A; Scott, Andrew M |
| 51 | 2022 | Antibody-drug conjugates: beyond current approvals and potential future strategies. | Menon, Siddharth; Parakh, Sagun ; Scott, Andrew M ; Gan, Hui K |
| 52 | 2016 | Antibody-mediated delivery of therapeutics for cancer therapy | Parakh, Sagun ; Parslow, Adam C; Gan, Hui K ; Scott, Andrew M |
| 53 | 27-Jan-2020 | Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre. | Nguyen, Mike ; Ng Ying Kin, Sean; Shum, Evonne; Wann, Alysson ; Tamjid, Babak ; Sahu, Arvind; Torres, Javier |
| 54 | 2019 | Are we Choosing Wisely® in radiation oncology practice - findings from an Australian population-based study. | Ong, Wee Loon ; Foroudi, Farshad ; Milne, Roger L; Millar, Jeremy L |
| 55 | 12-Jun-2009 | Arsenic trioxide associated toothache. | Siderov, Jim ; Duggan, John |
| 56 | 10-Jan-2024 | Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia. | Loh, Zoe ; Ashby, Michael; Van Veldhuizen, Ellie; Li, Wenlong; Chee, Ashlyn; Aung, Winpa; Lavrukhina, Yelena; Mason, George; Pelly, Tenille; Nedumannil, Rithin; Kosciejew, Serena; Mokoonlall, Mridula; Lim, Jonathan; Calov, Georgina; Butler, Llewyn; Hillebrand, Paulina; Beekman, Ashley; Rathnasekara, Greasha Kalani; Raj, Sonia; Zhang, Cathey; Yao, Yao; Iland, Harry; Grigg, Andrew P |
| 57 | Aug-2023 | Artificial Intelligence in Head and Neck Cancer: A Systematic Review of Systematic Reviews. | Mäkitie, Antti A; Alabi, Rasheed Omobolaji; Ng, Sweet Ping ; Takes, Robert P; Robbins, K Thomas; Ronen, Ohad; Shaha, Ashok R; Bradley, Patrick J; Saba, Nabil F; Nuyts, Sandra; Triantafyllou, Asterios; Piazza, Cesare; Rinaldo, Alessandra; Ferlito, Alfio |
| 58 | 1-Jul-2014 | ASPECCT: panitumumab versus cetuximab for colorectal cancer. | Hawkes, Eliza A ; Wong, Rachel |
| 59 | Apr-2020 | Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership survey. | Chan, Alexandre; Patel, Himanshu; Siderov, Jim ; Bubalo, Joseph; Foreman, Emma |
| 60 | Oct-2022 | Assessing the environment for engagement in health services: The Audit for Consumer Engagement (ACE) tool. | Chauhan, Ashfaq; Newman, Bronwyn; Walpola, Ramesh Lahiru; Seale, Holly; Manias, Elizabeth; Wilson, Carlene J ; Harrison, Reema |
